# A Study to Evaluate Fasting/Postprandial Serum Apolipoprotein B-48 (ApoB-48) Levels in Diabetic Participants With Normal to Moderately High Low Density Lipoprotein-C (LDL-C) Levels (MK-0653A-259 AM1)

> **NCT01333436** · NA · COMPLETED · sponsor: **Organon and Co** · enrollment: 93 (actual)

## Conditions studied

- Dyslipidemia
- Hypercholesterolemia

## Interventions

- **OTHER:** Test Meal

## Key facts

- **NCT ID:** NCT01333436
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07-20
- **Primary completion:** 2012-05-12
- **Final completion:** 2012-05-12
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2024-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01333436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01333436, "A Study to Evaluate Fasting/Postprandial Serum Apolipoprotein B-48 (ApoB-48) Levels in Diabetic Participants With Normal to Moderately High Low Density Lipoprotein-C (LDL-C) Levels (MK-0653A-259 AM1)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01333436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*